help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KANNER, R. E.
Right arrow Articles by CONNETT, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KANNER, R. E.
Right arrow Articles by CONNETT, J. E.

Am. J. Respir. Crit. Care Med., Volume 164, Number 3, August 2001, 358-364

Lower Respiratory Illnesses Promote FEV1 Decline in Current Smokers But Not Ex-Smokers with Mild Chronic Obstructive Pulmonary Disease
Results from the Lung Health Study

RICHARD E. KANNER, NICHOLAS R. ANTHONISEN, and JOHN E. CONNETT, for the Lung Health Study Research Group

University of Utah Health Sciences Center, Salt Lake City, Utah; and LHS Coordinating Center, Minneapolis, Minnesota

We analyzed Lung Health Study (LHS) data to assess the effect of self-reported lower respiratory illnesses resulting in physician visits (LRI) on lung function. Participants were 5,887 smokers aged 35-60 yr, FEV1/FVC < 0.70 and FEV1 of 55-90% predicted. Two-thirds were randomized into an intensive smoking cessation program (SI); one-third were advised only to stop smoking (UC). For 5 yr participants had annual spirometry and questioning regarding LRI. SI had greater rates of smoking cessation than usual care (UC) with fewer LRI (p = 0.0008). Sustained quitters had fewer LRI than continuing smokers (p = 0.0003). In the year LRI occurred, FEV1 did not change in sustained quitters, but decreased significantly in smokers (p = 0.0001) with some recovery the following year if no LRI occurred. Over 5 yr, LRI had a significant effect on rate of decline of FEV1 only in smokers. In smokers averaging one LRI/yr over 5 yr there were additional declines in FEV1 of 7 ml /yr (p = 0.001). Smokers with more than one LRI/yr had greater declines. Chronic bronchitis was associated with increased frequencies of LRI, but did not affect their influence on lung function. Smoking and LRI had an interactive effect on FEV1 in people with mild COPD, and in smokers frequent LRI may influence the long-term course of the disease.

Keywords: smoking; chronic obstructive pulmonary disease; lower respiratory infections; chronic bronchitis




This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
N. Patel, M. DeCamp, and G. J. Criner
Lung Transplantation and Lung Volume Reduction Surgery versus Transplantation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 447 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
O. A. Minai, J. Benditt, and F. J. Martinez
Natural History of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 468 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Sethi, C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T. F. Murphy
Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 491 - 497.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. H. Groenewegen, D. S. Postma, W. C. J. Hop, P. L. M. L. Wielders, N. J. J. Schlosser, E. F. M. Wouters, and for the COSMIC Study Group
Increased Systemic Inflammation Is a Risk Factor for COPD Exacerbations
Chest, February 1, 2008; 133(2): 350 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. B. Snoeck-Stroband, T. S. Lapperre, M. M. E. Gosman, H. M. Boezen, W. Timens, N. H. T. ten Hacken, J. K. Sont, P. J. Sterk, P. S. Hiemstra, and the Groningen Leiden Universities Corticosteroids
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Eur. Respir. J., January 1, 2008; 31(1): 70 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. K. Silverman
Exacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression?
Proceedings of the ATS, December 1, 2007; 4(8): 586 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
H. Abusriwil and R. A. Stockley
The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage
Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. J. Martinez
Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 647 - 658.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P M A Calverley and J A Wedzicha
Chronic obstructive pulmonary disease past, present and future
Thorax, December 1, 2007; 62(12): 1026 - 1027.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Bourbeau, G. Ford, H. Zackon, N. Pinsky, J. Lee, and G. Ruberto
Impact on patients' health status following early identification of a COPD exacerbation
Eur. Respir. J., November 1, 2007; 30(5): 907 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
M. Miravitlles
Review: Do we need new antibiotics for treating exacerbations of COPD?
Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 61 - 76.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
I. I. Siempos, G. Dimopoulos, I. P. Korbila, K. Manta, and M. E. Falagas
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis
Eur. Respir. J., June 1, 2007; 29(6): 1127 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Tsoumakidou, W. Elston, J. Zhu, Z. Wang, E. Gamble, N. M. Siafakas, N. C. Barnes, and P. K. Jeffery
Cigarette Smoking Alters Bronchial Mucosal Immunity in Asthma
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 919 - 925.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Stolz, M. Christ-Crain, N. G. Morgenthaler, J. Leuppi, D. Miedinger, R. Bingisser, C. Muller, J. Struck, B. Muller, and M. Tamm
Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD
Chest, April 1, 2007; 131(4): 1058 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. G. Cote, L. J. Dordelly, and B. R. Celli
Impact of COPD Exacerbations on Patient-Centered Outcomes
Chest, March 1, 2007; 131(3): 696 - 704.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, R. J. Sapsford, H. Mullerova, G. C. Donaldson, and J. A. Wedzicha
Inflammatory changes, recovery and recurrence at COPD exacerbation
Eur. Respir. J., March 1, 2007; 29(3): 527 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier
Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 144 - 149.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. E. Niewoehner, Y. Lokhnygina, K. Rice, W. G. Kuschner, A. Sharafkhaneh, G. A. Sarosi, P. Krumpe, K. Pieper, and S. Kesten
Risk Indexes for Exacerbations and Hospitalizations Due to COPD
Chest, January 1, 2007; 131(1): 20 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Roghanian, E. M. Drost, W. MacNee, S. E. M. Howie, and J.-M. Sallenave
Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase
Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1189 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I. E. Rascon-Aguilar, M. Pamer, P. Wludyka, J. Cury, D. Coultas, L. R. Lambiase, N. S. Nahman, and K. J. Vega
Role of Gastroesophageal Reflux Symptoms in Exacerbations of COPD.
Chest, October 1, 2006; 130(4): 1096 - 1101.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. M. Fernaays, A. J. Lesse, S. Sethi, X. Cai, and T. F. Murphy
Differential Genome Contents of Nontypeable Haemophilus influenzae Strains from Adults with Chronic Obstructive Pulmonary Disease.
Infect. Immun., June 1, 2006; 74(6): 3366 - 3374.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Papi, F. Luppi, F. Franco, and L. M. Fabbri
Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2006; 3(3): 245 - 251.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Wilson, P Jones, T Schaberg, P Arvis, I Duprat-Lomon, P P Sagnier, and for the MOSAIC Study Group
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis
Thorax, April 1, 2006; 61(4): 337 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Dusser, M-L. Bravo, P. Iacono, and on behalf the MISTRAL study group
The effect of tiotropium on exacerbations and airflow in patients with COPD.
Eur. Respir. J., March 1, 2006; 27(3): 547 - 555.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G C Donaldson and J A Wedzicha
COPD exacerbations {middle dot} 1: Epidemiology
Thorax, February 1, 2006; 61(2): 164 - 168.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Vestbo and J C Hogg
Convergence of the epidemiology and pathology of COPD
Thorax, January 1, 2006; 61(1): 86 - 88.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. S. Braman
Chronic Cough Due to Chronic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 104S - 115S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. J. Stevenson, P. P. Walker, R. W. Costello, and P. M. A. Calverley
Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1510 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
G. B. Toews
Impact of bacterial infections on airway diseases
Eur. Respir. Rev., December 1, 2005; 14(95): 62 - 68.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
M. Soler
Modulation of airway inflammation to prevent exacerbations of COPD
Eur. Respir. Rev., December 1, 2005; 14(95): 78 - 82.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J A Wedzicha and T A R Seemungal
Inhaled corticosteroids in COPD: a light at the end of the tunnel?
Thorax, December 1, 2005; 60(12): 977 - 978.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
P. W. Ind
COPD disease progression and airway inflammation: uncoupled by smoking cessation
Eur. Respir. J., November 1, 2005; 26(5): 764 - 766.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. Mallia and S. L. Johnston
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS, November 1, 2005; 2(4): 361 - 366.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J J Soler-Cataluna, M A Martinez-Garcia, P Roman Sanchez, E Salcedo, M Navarro, and R Ochando
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Thorax, November 1, 2005; 60(11): 925 - 931.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. C. Donaldson, T. A. R. Seemungal, I. S. Patel, A. Bhowmik, T. M. A. Wilkinson, J. R. Hurst, P. K. MacCallum, and J. A. Wedzicha
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Chest, October 1, 2005; 128(4): 1995 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
D. E. Niewoehner, K. Rice, C. Cote, D. Paulson, J. A. D. Cooper Jr., L. Korducki, C. Cassino, and S. Kesten
Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial
Ann Intern Med, September 6, 2005; 143(5): 317 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Calverley, R. Pauwels{dagger}, C-G. Lofdahl, K. Svensson, T. Higenbottam, L-G. Carlsson, and E. Stahl
Relationship between respiratory symptoms and medical treatment in exacerbations of COPD
Eur. Respir. J., September 1, 2005; 26(3): 406 - 413.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
W. Vincken
Bronchodilator treatment of stable COPD: long-acting anticholinergics
Eur. Respir. Rev., September 1, 2005; 14(94): 23 - 31.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
R. Wilson
Treatment of COPD exacerbations: antibiotics
Eur. Respir. Rev., September 1, 2005; 14(94): 32 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Hoogendoorn, M. P. M. H. Rutten-van Molken, R. T. Hoogenveen, M. L. L. van Genugten, A. S. Buist, E. F. M. Wouters, and T. L. Feenstra
A dynamic population model of disease progression in COPD
Eur. Respir. J., August 1, 2005; 26(2): 223 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Needham and R. A. Stockley
Exacerbations in {alpha}1-antitrypsin deficiency
Eur. Respir. J., June 1, 2005; 25(6): 992 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Decramer, R Gosselink, P Bartsch, C-G Lofdahl, W Vincken, R Dekhuijzen, J Vestbo, R Pauwels, R Naeije, and T Troosters
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004
Thorax, April 1, 2005; 60(4): 343 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. C. Donaldson, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, and J. A. Wedzicha
Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 446 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
J R Hurst and J A Wedzicha
Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation
Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
J Vestbo
Chronic bronchitis: should it worry us?
Chronic Respiratory Disease, July 1, 2004; 1(3): 173 - 176.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Paggiaro
Does Early Treatment of Exacerbation Improve Outcome in Chronic Obstructive Pulmonary Disease?
Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1267 - 1268.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. M. A. Wilkinson, G. C. Donaldson, J. R. Hurst, T. A. R. Seemungal, and J. A. Wedzicha
Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1298 - 1303.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N.R. Anthonisen
The British hypothesis revisited
Eur. Respir. J., May 1, 2004; 23(5): 657 - 658.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Spencer, P.M.A. Calverley, P.S. Burge, and P.W. Jones
Impact of preventing exacerbations on deterioration of health status in COPD
Eur. Respir. J., May 1, 2004; 23(5): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. W. Waterer and S. E. Temple
Do We Really Want To Know Why Only Some Smokers Get COPD?
Chest, May 1, 2004; 125(5): 1599 - 1600.
[Full Text] [PDF]

Home page
 ThoraxHome page
M Miravitlles, M Ferrer, A Pont, R Zalacain, J L Alvarez-Sala, F Masa, H Verea, C Murio, F Ros, and R Vidal
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study
Thorax, May 1, 2004; 59(5): 387 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. A. Pauwels
Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS, April 1, 2004; 1(2): 73 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. I. Rennard and S. G. Farmer
Exacerbations and Progression of Disease in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 88 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. Sethi
Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease: Phenomenon or Epiphenomenon?
Proceedings of the ATS, April 1, 2004; 1(2): 109 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
J. A. Wedzicha
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 115 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
N. R. Anthonisen
Lessons from the Lung Health Study
Proceedings of the ATS, April 1, 2004; 1(2): 143 - 145.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
G.C. Donaldson, T.A.R. Seemungal, I.S. Patel, S.J. Lloyd-Owen, T.M.A. Wilkinson, and J.A. Wedzicha
Longitudinal changes in the nature, severity and frequency of COPD exacerbations
Eur. Respir. J., December 1, 2003; 22(6): 931 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J., October 1, 2003; 22(4): 672 - 688.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J White, S Gompertz, D L Bayley, S L Hill, C O'Brien, I Unsal, and R A Stockley
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis
Thorax, August 1, 2003; 58(8): 680 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. W. Chien, P. J. Martin, T. A. Gooley, M. E. Flowers, S. R. Heckbert, W. G. Nichols, and J. G. Clark
Airflow Obstruction after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 208 - 214.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Burge and J.A. Wedzicha
COPD exacerbations: definitions and classifications
Eur. Respir. J., June 1, 2003; 21(41_suppl): 46S - 53s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. M. A. Wilkinson, I. S. Patel, M. Wilks, G. C. Donaldson, and J. A. Wedzicha
Airway Bacterial Load and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1090 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
W A Biernacki, S A Kharitonov, and P J Barnes
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD
Thorax, April 1, 2003; 58(4): 294 - 298.
[Abstract] [Full Text] [PDF]